Mark Bradley Wilson

Country/Region of practice
United States
About
Please contact this individual for more details

FICPI Honour

  • Member of Honour

Roles in FICPI

  • CET 5 Biotechnology and Pharmaceuticals

    CET Group 5 is dedicated to following, reporting and providing substantive comments and opinions on emerging issues relating to the patenting and regulatory affairs in the Biotechnology and Pharmaceutical fields. 

    In addition, CET 5 is closely following developments related to genetic resources and developing requirements for notice on their country of origin.  Prominent issues CET 5 addresses regarding patenting in these technological fields include subject matter eligibility, and in particular, the patentability of chemical/biological inventions developed using machines, computer implementation and/or artificial intelligence.  CET 5 supports FICPI in its mission to be an international leader promoting patent protection in the biotechnology and pharmaceutical arts.

  • Member
CONTACT MEMBER